THE GLOBAL INSULIN PENS MARKET SIZE WAS VALUED AT USD 1.09 BILLION IN 2021 AND IS EXPECTED TO REACH USD 1.57 BILLION BY 2027, GROWING AT A CAGR OF 6.26% DURING THE FORECAST PERIOD

The Insulin Pens Market Size, Share, Trends Analysis, Competitive Landscape, and Growth Potential by

  • Product: Traditional and Smart
  • Usage: Disposable and Reusable
  • Distribution Channel: Hospitals & Clinics, Standalone Pharmacies, and Online
  • Geography: North America, Europe, APAC, Latin America, and the Middle East & Africa 

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

260 Pages

icon-table

69 Tables

icon-chart

125 Charts

icon-region

5 Regions

icon-country

19 Countries

icon-company

17 Companies

icon-market

5 Market Segment

INSULIN PENS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (2021) USD 1.09 MILLION
MARKET SIZE (2027) USD 1567.10 MILLION
CAGR 6.26% (2022-2027)
BASE YEAR 2021
FORECAST YEAR 2022-2027
MARKET SEGMENTS Product (Traditional and Smart), Usage (Disposable and Reusable), Distribution Channel (Hospitals & Clinics, Standalone Pharmacies, and Online)
GEOGRAPHIC ANALYSIS North America, Europe, APAC, Latin America, and Middle East & Africa
COUNTRIES COVERED Germany, UK, France, Spain, Italy, US, Canada, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, South Africa, Saudi Arabia, UAE

MARKET INSIGHTS 

The insulin pens market was valued at USD 1.09 billion in 2021 and is expected to reach USD 1.57 billion by 2027, growing at a CAGR of 6.26% from 2022 to 2027. Insulin pens are delivery devices that deliver insulin under the skin for diabetic management. There are disposable and refillable insulin pens. Due to the ease of usage and portable and handier nature the insulin pens, demand is increasing worldwide. People with type-1 diabetes have multiple technologies for better health management. Insulin pens are one of those advanced devices which are gaining traction.  

SMART INSULIN PENS TO REVOLUTIONIZE THE GLOBAL INSULIN PENS MARKET 

The advancements in the insulin pens include the introduction of smart insulin pens, which can be connected to the device that stores the history of insulin dosage and time, which helps the patients to manage their insulin dosing better. These smart insulin pens are revolutionizing the insulin pen market. A significant preference for diabetes pen usage is the accuracy in taking up the insulin doses, which is lacking in the syringes. Some of the limitations in insulin pen usage include increased frequency of administering the insulin by patients compared to insulin pumps.  

Rise In The Diabetic Population To Boost The Market Growth

The constant rise in the diabetic population across the globe is one of the major drivers increasing the adoption of insulin pens. Insulin pen adoption is higher in developed countries compared to developing and underdeveloped countries. One of the significant limitations is the cost and lack of proper reimbursement, limiting the usage of diabetes pens across the countries. In addition, a large number of undiagnosed diabetic populations across the globe also limits the usage of insulin devices.  

Insulin pen manufacturers invest in product launches, mainly in the smart insulin pen segment. For instance, Medtronic InPen (Bluetooth-enabled insulin pen) received FDA clearance in 2020 for all ages. NovoPen 6 -a smart insulin pen from Novo Nordisk in 2019 and more. The product launches were less from 2021 to 2022 due to the COVID-19 pandemic. It is expected to increase after the market resumes normal post-pandemic.  

Impact Of COVID-19 On The Global Insulin Pen Market

COVID-19 had a neutral impact on the global insulin pen market. The demand was high as diabetic patients were high-risk populations for COVID-19 infection. This increased the pressure on diabetic patients to manage their health consciously. However, due to lockdown supply chain issues, the availability of diabetes pens was limited. Due to the economic pressure and job cuts during the large pandemic, patients shifted to using insulin syringes because of their affordable costs. This impacted the market negatively. 

Traditional Insulin Pens Remain The Most Preferred Devices

The traditional insulin pens are largely preferred due to their larger adoption and ease to use. These pens are still preferred among the elderly population (above 50 years) as they must attach the needle and inject it, which is prefilled and lasts for a longer time, with accurate dosing. Not many advancements are seen in the traditional diabetes injection devices as patients are already shifting towards the usage of smart insulin pens. However, the demand for smart insulin pens is increasing as they are more informative and help patients manage their health better. Smart insulin pens can streamline the data across multiple platforms like smart apps, blood glucose monitoring devices, etc. This helps them to manage diabetes in a better way.  

Introduction of Low-Cost Insulin To Drive The Demand For Reusable Insulin Pens

 

Due to low maintenance and single usability, the demand for disposable insulin pens is growing. Re-usable insulin devices have the advantage that only refillable insulin cartridges need to be purchased and used. This reduces the cost of the total insulin pen cost. However, some companies are already working on manufacturing low-cost insulin; post-approval of low-cost insulin, the demand for re-usable diabetes pens might increase over disposable diabetes pens.  

COVID-19 has Accelerated The Online Sales

Hospitals & clinics are the largest distribution channels in the global insulin pens market. Patients prefer purchasing diabetes pens from hospitals and clinics as they are the first point of contact for purchasing the product. Over time, the online channel is picking up the phase; there is a shift towards using online channels to purchase insulin pens in the market. The COVID-19 pandemic further accelerated the preference of online channels for purchasing insulin pens. There was a shortage and high chances of contracting COVID-19 infections in pharmacies and other healthcare settings.   

Increasing Awareness Among Consumers To Push The APAC Insulin Pen Market Growth

 

Europe region dominated the insulin pen market by geography due to their higher adoption of insulin pens than syringes. The diabetes pens market in APAC posts a higher CAGR than other regions because of their increased target population, raising awareness regarding the insulin pens.  

The North American region, especially the US considered one of the attractive markets for diabetic products, and many new companies are entering the market to attract customers. For instance, Biocon & Mylan launched a new insulin pen at an affordable cost in the US market compared to other existing products. This is expected to enhance competition among the vendors in the US insulin pen market landscape. Due to the lack of awareness and economic conditions, the Latin America & Middle East & Africa regions occupy a negligible insulin pens market share.  

Frequently Asked Questions

What is the growth rate of the insulin pens market?

The growth rate of the insulin pens market is 6.26% in the forecast period

Which region has the highest growth rate in the insulin pens industry?

APAC region has the highest growth rate.

Who are the key players in the Insulin Pens industry?

The key players are Lilly, Medtronic, Novo Nordisk, and Sanofi.

Which segment of product type is dominating the injection pens market?

The traditional insulin pens segment is dominating the injection pens market.

What are some opportunities and trends in the insulin pens market?

Technological advancements in insulin pens, increased demand for smart insulin pens, and the rising prevalence of diabetes are some opportunities in the market.

Download Free Sample

The insulin pens market was valued at USD 1.1 billion in 2021 and is expected to reach USD 1.5 billion by 2027, growing at a CAGR of  6.26% during the forecast period

The following factors are likely to contribute to the growth of the insulin pens market-

  • Technological Advancements in Insulin Pens
  • Increased Demand for Smart Insulin Pens
  • Introduction of Integrated Smart Pen Systems
  • Rising Prevalence of Diabetes
  • Increasing Usage of Insulin Pens for Ambulatory Use

Base Year: 2021

Forecast Year: 2022-2027

The study considers a detailed scenario of the present insulin pens market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

KEY VENDORS

 

  • Lilly
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Medtronic
  • Novo Nordisk
  • Sanofi

OTHER PROMINENT VENDORS

  • BD
    • Business Overview
    • Product Offerings
  • Biocon
  • Pendiq
  • Emperra
  • Guangzhou Medsinglong Medical Equipment
  • HK Zion Industry
  • Jiangsu Delfu Medical Device
  • Owen Mumford
  • Shanghai Umitai Medical Technology
  • Sun Medical Products
  • Suzhou Peng Ye Medical Technology Co., Ltd.
  • Triones Technology (Guangzhou)
  • Ypsomed

Segmentation by Product

  • Traditional Insulin Pens
  • Smart Insulin Pens

Segmentation by Usage

  • Disposable Insulin Pens
  • Reusable Insulin Pens

Segmentation by Distribution Channel

  • Hospitals & Clinics
  • Standalone Pharmacies
  • Online

Segmentation by Geography

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • North America
    • US
    • Canada
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia
    • UAE

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY USAGE

4.3.3 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

8.1 TECHNOLOGICAL ADVANCEMENTS IN INSULIN PENS

8.2 INCREASED DEMAND FOR SMART INSULIN PENS

8.3 INTRODUCTION OF INTEGRATED SMART PEN SYSTEMS

9 MARKET GROWTH ENABLERS

9.1 RISING PREVALENCE OF DIABETES

9.2 INCREASED USE OF INSULIN PENS IN AMBULATORY SETTINGS

9.3 GROWTH IN PRODUCT LAUNCHES

10 MARKET GROWTH RESTRAINTS

10.1 COMPLICATIONS ASSOCIATED WITH INSULIN PENS

10.2 HIGH COST & LACK OF UNIVERSAL INSURANCE COVERAGE

10.3 LARGE POPULATIONS WITH UNDIAGNOSED DIABETES

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 PRODUCT INSIGHTS

11.2.2 USAGE INSIGHTS

11.2.3 DISTRIBUTION CHANNEL INSIGHTS

11.2.4 GEOGRAPHY INSIGHTS

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 PRODUCT

12.1 MARKET SNAPSHOT & GROWTH ENGINE

12.2 MARKET OVERVIEW

12.3 TRADITIONAL INSULIN PENS

12.3.1 MARKET OVERVIEW

12.3.2 MARKET SIZE & FORECAST

12.3.3 TRADITIONAL INSULIN PENS BY GEOGRAPHY

12.4 SMART INSULIN PENS

12.4.1 MARKET OVERVIEW

12.4.2 MARKET SIZE & FORECAST

12.4.3 SMART INSULIN PENS BY GEOGRAPHY

13 USAGE

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 DISPOSABLE INSULIN PENS

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 DISPOSABLE INSULIN PENS BY GEOGRAPHY

13.4 REUSABLE INSULIN PENS

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 REUSABLE INSULIN PENS BY GEOGRAPHY

14 DISTRIBUTION CHANNEL

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 HOSPITALS & CLINICS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 HOSPITALS & CLINICS BY GEOGRAPHY

14.4 STANDALONE PHARMACIES

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 STANDALONE PHARMACIES BY GEOGRAPHY

14.5 ONLINE

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 ONLINE BY GEOGRAPHY

15 GEOGRAPHY

15.1 GEOGRAPHIC OVERVIEW

15.2 MARKET SNAPSHOT & GROWTH ENGINE

16 EUROPE

16.1 MARKET OVERVIEW

16.2 MARKET SIZE & FORECAST

16.3 EUROPE: MARKET BY PRODUCT

16.4 EUROPE: MARKET BY USAGE

16.5 EUROPE: DISTRIBUTION CHANNEL

16.7 KEY COUNTRIES

16.7.1 GERMANY: MARKET SIZE & FORECAST

16.7.2 FRANCE: MARKET SIZE & FORECAST

16.7.3 UK: MARKET SIZE & FORECAST

16.7.4 ITALY: MARKET SIZE & FORECAST

16.7.5 SPAIN: MARKET SIZE & FORECAST

17 NORTH AMERICA

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 NORTH AMERICA: MARKET BY PRODUCT

17.4 NORTH AMERICA: MARKET BY USAGE

17.5 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNEL

17.7 KEY COUNTRIES

17.7.1 US: MARKET SIZE & FORECAST

17.7.2 CANADA: MARKET SIZE & FORECAST

18 APAC

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 APAC: MARKET BY PRODUCT

18.4 APAC: MARKET BY USAGE

18.5 APAC: MARKET BY DISTRIBUTION CHANNEL

18.6 KEY COUNTRIES

18.6.1 CHINA: MARKET SIZE & FORECAST

18.6.2 JAPAN: MARKET SIZE & FORECAST

18.6.3 INDIA: MARKET SIZE & FORECAST

18.6.4 SOUTH KOREA: MARKET SIZE & FORECAST

18.6.5 AUSTRALIA: MARKET SIZE & FORECAST

19 LATIN AMERICA

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 LATIN AMERICA: MARKET BY PRODUCT

19.4 LATIN AMERICA: MARKET BY USAGE

19.5 LATIN: MARKET BY DISTRIBUTION CHANNEL

19.6 KEY COUNTRIES

19.6.1 BRAZIL: MARKET SIZE & FORECAST

19.6.2 MEXICO: MARKET SIZE & FORECAST

19.6.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 MIDDLE EAST & AFRICA: MARKET BY PRODUCT

20.4 MIDDLE EAST & AFRICA: MARKET BY USAGE

20.5 MIDDLE EAST & AFRICA: MARKET BY DISTRIBUTION CHANNEL

20.6 KEY COUNTRIES

20.6.1 TURKEY: MARKET SIZE & FORECAST

20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST

20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST

20.6.4 UAE: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

21.2 MARKET SHARE ANALYSIS

21.2.1 LILLY

21.2.2 MEDTRONIC

21.2.3 NOVO NORDISK

21.2.4 SANOFI

22 KEY COMPANY PROFILES

22.1 LILLY

22.1.1 BUSINESS OVERVIEW

22.1.2 PRODUCT OFFERINGS

22.1.3 KEY STRATEGIES

22.1.4 KEY STRENGTHS

22.1.5 KEY OPPORTUNITIES

22.2 MEDTRONIC

22.2.1 BUSINESS OVERVIEW

22.2.2 PRODUCT OFFERINGS

22.2.3 KEY STRATEGIES

22.2.4 KEY STRENGTHS

22.2.5 KEY OPPORTUNITIES

22.3 NOVO NORDISK

22.3.1 BUSINESS OVERVIEW

22.3.2 PRODUCT OFFERINGS

22.3.3 KEY STRATEGIES

22.3.4 KEY STRENGTHS

22.3.5 KEY OPPORTUNITIES

22.4 SANOFI

22.4.1 BUSINESS OVERVIEW

22.4.2 PRODUCT OFFERINGS

22.4.3 KEY STRATEGIES

22.4.4 KEY STRENGTHS

22.4.5 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

23.1 BD

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERINGS

23.2 BIOCON

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERINGS

23.3 EMPERRA GMBH E-HEALTH TECHNOLOGIES

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERINGS

23.4 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT

23.4.1 BUSINESS OVERVIEW

23.4.2 PRODUCT OFFERINGS

23.5 HK ZION INDUSTRY

23.5.1 BUSINESS OVERVIEW

23.5.2 PRODUCT OFFERINGS

23.6 JIANGSU DELFU MEDICAL DEVICE

23.6.1 BUSINESS OVERVIEW

23.6.2 PRODUCT OFFERINGS

23.7 OWEN MUMFORD

23.7.1 BUSINESS OVERVIEW

23.7.2 PRODUCT OFFERINGS

23.8 PENDIQ

23.8.1 BUSINESS OVERVIEW

23.8.2 PRODUCT OFFERINGS

23.9 SHANGHAI UMITAI MEDICAL TECHNOLOGY

23.9.1 BUSINESS OVERVIEW

23.9.2 PRODUCT OFFERINGS

23.10 SUN MEDICAL PRODUCTS

23.10.1 BUSINESS OVERVIEW

23.10.2 PRODUCT OFFERINGS

23.11 SUZHOU PENG YE MEDICAL DEVICES

23.11.1 BUSINESS OVERVIEW

23.11.2 PRODUCT OFFERINGS

23.12 TRIONES TECHNOLOGY

23.12.1 BUSINESS OVERVIEW

23.12.2 PRODUCT OFFERINGS

23.13 YPSOMED

23.13.1 BUSINESS OVERVIEW

23.13.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

24.1 KEY TAKEAWAYS

24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

25.1 MARKET BY GEOGRAPHY

25.2 MARKET BY PRODUCT

25.3 MARKET BY USAGE

25.4 MARKET BY DISTRIBUTION CHANNEL

25.5 NORTH AMERICA: MARKET BY PRODUCT

25.6 NORTH AMERICA: MARKET BY USAGE

25.7 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNEL

25.8 APAC: MARKET BY PRODUCT

25.9 APAC: MARKET BY USAGE

25.10 APAC: MARKET BY DISTRIBUTION CHANNEL

25.11 EUROPE: MARKET BY PRODUCT

25.12 EUROPE: MARKET BY USAGE

25.13 EUROPE: MARKET BY DISTRIBUTION CHANNEL

25.14 LATIN AMERICA: MARKET BY PRODUCT

25.15 LATIN AMERICA: MARKET BY USAGE

25.16 LATIN AMERICA: MARKET BY DISTRIBUTION CHANNEL

25.17 MIDDLE EAST & AFRICA: MARKET BY PRODUCT

25.18 MIDDLE EAST & AFRICA: MARKET BY USAGE

25.19 MIDDLE EAST & AFRICA: MARKET BY DISTRIBUTION CHANNEL

26 APPENDIX

26.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL INSULIN PENS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 PREVALENCE OF TYPE-2 DIABETES IN ADULTS (20-79 YEARS) 2019, 2030, & 2045 BY GEOGRAPHY

EXHIBIT 4 IMPACT OF TECHNOLOGICAL ADVANCEMENTS IN INSULIN PENS

EXHIBIT 5 IMPACT OF INCREASED DEMAND FOR SMART INSULIN PENS

EXHIBIT 6 TOTAL COST OF SMART INSULIN PENS & STANDARD CARE FOR NON-SEVERE HYPOGLYCEMIA IN SWEDEN ($)

EXHIBIT 7 IMPACT OF INTRODUCTION OF INTEGRATED SMART PEN SYSTEMS

EXHIBIT 8 IMPACT OF RISING PREVALENCE OF DIABETES

EXHIBIT 9 PREVALENCE OF DIABETES IN ADULTS (20-79 AGE GROUP) ACCORDING TO IDF

EXHIBIT 10 DEATHS OF DIABETIC POPULATION IN 20-79 AGE GROUP 2019

EXHIBIT 11 IMPACT OF INCREASING USAGE OF INSULIN PENS FOR AMBULATORY PURPOSES

EXHIBIT 12 IMPACT OF GROWTH IN PRODUCT LAUNCHES

EXHIBIT 13 IMPACT OF COMPLICATIONS ASSOCIATED WITH INSULIN PENS

EXHIBIT 14 IMPACT OF HIGH COST & LACK OF UNIVERSAL INSURANCE COVERAGE

EXHIBIT 15 IMPACT OF LARGE POPULATIONS WITH UNDIAGNOSED DIABETES

EXHIBIT 16 GLOBAL UNDIAGNOSED DIABETES POPULATION AGED BETWEEN 20-79 (%)

EXHIBIT 17 GLOBAL INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 18 GLOBAL INSULIN PENS MARKET SHARE BY PRODUCT 2021 & 2027 (%)

EXHIBIT 19 GLOBAL INSULIN PENS MARKET SHARE BY USAGE 2021 & 2027 (%)

EXHIBIT 20 GLOBAL INSULIN PENS MARKET SHARE BY DISTRIBUTION CHANNEL 2021 & 2027 (%)

EXHIBIT 21 GLOBAL INSULIN PENS MARKET SHARE BY GEOGRAPHY 2021 & 2027 (%)

EXHIBIT 22 FIVE FORCES ANALYSIS 2021

EXHIBIT 23 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 24 GLOBAL INSULIN PENS MARKET BY PRODUCT TYPE

EXHIBIT 25 GLOBAL INSULIN PENS MARKET BY PRODUCT: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 26 GLOBAL INSULIN PENS MARKET BY PRODUCT: ABSOLUTE GROWTH (%)

EXHIBIT 27 ADVANTAGES OF INSULIN PENS OVER SYRINGES

EXHIBIT 28 SOME TRADITIONAL INSULIN PENS OFFERED BY NOVO NORDISK

EXHIBIT 29 GLOBAL TRADITIONAL INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 30 GLOBAL TRADITIONAL INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 31 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 32 GLOBAL SMART INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 33 GLOBAL SMART INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 34 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 35 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 36 GLOBAL INSULIN PENS MARKET BY USAGE

EXHIBIT 37 GLOBAL INSULIN PENS MARKET BY USAGE: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 38 GLOBAL DISPOSABLE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 39 GLOBAL DISPOSABLE INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 40 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 41 GLOBAL REUSABLE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 42 GLOBAL REUSABLE INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 44 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL BY 2021 & 2027

EXHIBIT 45 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL

EXHIBIT 46 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 47 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL: ABSOLUTE GROWTH (%)

EXHIBIT 48 GLOBAL INSULIN PENS MARKET BY HOSPITALS & CLINICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 49 GLOBAL HOSPITALS & CLINICS INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 51 GLOBAL INSULIN PENS MARKET BY STANDALONE PHARMACIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL STANDALONE PHARMACIES INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 54 GLOBAL ONLINE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL ONLINE INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 57 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY

EXHIBIT 58 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 59 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)

EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 62 EUROPE INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 63 EUROPE INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 64 EUROPE INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 65 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 66 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 67 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 68 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 69 INSULIN PENS MARKET IN GERMANY 2021–2027 ($ MILLION)

EXHIBIT 70 INSULIN PENS MARKET IN FRANCE 2021–2027 ($ MILLION)

EXHIBIT 71 INSULIN PENS MARKET IN UK 2021–2027 ($ MILLION)

EXHIBIT 72 INSULIN PENS MARKET IN ITALY 2021–2027 ($ MILLION)

EXHIBIT 73 INSULIN PENS MARKET IN SPAIN 2021–2027 ($ MILLION)

EXHIBIT 74 NORTH AMERICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 75 NORTH AMERICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 76 NORTH AMERICA INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 77 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 78 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 79 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 80 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 81 INSULIN PENS MARKET IN US 2021–2027 ($ MILLION)

EXHIBIT 82 INSULIN PENS MARKET IN CANADA 2021–2027 ($ MILLION)

EXHIBIT 83 APAC INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 84 APAC INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 85 APAC INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 86 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 87 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 88 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 89 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 90 INSULIN PENS MARKET IN CHINA 2021–2027 ($ MILLION)

EXHIBIT 91 INSULIN PENS MARKET IN JAPAN 2021–2027 ($ MILLION)

EXHIBIT 92 INSULIN PENS MARKET IN INDIA 2021–2027 ($ MILLION)

EXHIBIT 93 INSULIN PENS MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)

EXHIBIT 94 INSULIN PENS MARKET IN AUSTRALIA 2021–2027 ($ MILLION)

EXHIBIT 95 LATIN AMERICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 96 LATIN AMERICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 97 LATIN AMERICA INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 98 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 99 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 100 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 101 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 102 INSULIN PENS MARKET IN BRAZIL 2021–2027 ($ MILLION)

EXHIBIT 103 INSULIN PENS MARKET IN MEXICO 2021–2027 ($ MILLION)

EXHIBIT 104 INSULIN PENS MARKET IN ARGENTINA 2021–2027 ($ MILLION)

EXHIBIT 105 MIDDLE EAST & AFRICA INSULIN PENS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 106 MIDDLE EAST & AFRICA INSULIN PENS MARKET: KEY COUNTRIES 2021($ MILLION)

EXHIBIT 107 MIDDLE EAST & AFRICA INSULIN PENS MARKET 2021–2027 ($ MILLION)

EXHIBIT 108 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 109 INCREMENTAL GROWTH BY USAGE 2021 & 2027

EXHIBIT 110 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2021 & 2027

EXHIBIT 111 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 112 INSULIN PENS MARKET IN TURKEY 2021–2027 ($ MILLION)

EXHIBIT 113 INSULIN PENS MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)

EXHIBIT 114 INSULIN PENS MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)

EXHIBIT 115 INSULIN PENS MARKET IN UAE 2021–2027 ($ MILLION)

EXHIBIT 116 LILLY: MARKET SHARE BY GEOGRAPHY 2020 (%)

EXHIBIT 117 LILLY: TOTAL REVENUE 2018-2020 ($ MILLION)

EXHIBIT 118 MEDTRONIC: TOTAL REVENUE BY DIABETES CARE SEGMENT 2018–2020 ($ MILLION)

EXHIBIT 119 MEDTRONIC: MARKET SHARE OF DIABETES CARE BY GEOGRAPHY (%)

EXHIBIT 120 NOVO NORDISK: MARKET SHARE BY GEOGRAPHY 2020 (%)

EXHIBIT 121 NOVO NORDISK: MARKET SHARE BY SEGMENTS 2020 (%)

EXHIBIT 122 NOVO NORDISK: REVENUE 2019–2020 ($ BILLION)

EXHIBIT 123 SANOFI: MARKET SHARE BY SEGMENTS 2020 (%)

EXHIBIT 124 SANOFI: TOTAL REVENUE BY PHARMACEUTICAL SEGMENT 2018–2020 ($ MILLION)

EXHIBIT 125 SANOFI: MARKET SHARE OF PHARMACEUTICAL SEGMENT BY GEOGRAPHY 2020 (%)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 ADVANTAGES & DISADVANTAGES OF INSULIN PENS

TABLE 4 OVERVIEW OF INSULIN PEN ATTACHMENTS

TABLE 5 KEY ADVANCED INSULIN PENS IN MARKET

TABLE 6 OVERVIEW OF SMART CAPS

TABLE 7 GLOBAL DIABETES MARKET SIZE ($ MILLION)

TABLE 8 FACTORS INCREASING DIABETES PREVALENCE WORLDWIDE

TABLE 9 INSULIN PENS LAUNCHED IN RECENT YEARS

TABLE 10 AVERAGE PRICE OF INSULIN PENS & INSULIN VIALS PER PACKAGE & PER MONTH

TABLE 11 TRADITIONAL INSULIN PENS OFFERED BY OTHER COMPANIES

TABLE 12 SMART INSULIN PENS FROM VARIOUS COMPANIES

TABLE 13 LIST OF COMMONLY USED DISPOSABLE INSULIN PENS

TABLE 14 LIST OF COMMONLY USED REUSABLE INSULIN PENS

TABLE 15 LILLY: MAJOR PRODUCT OFFERINGS

TABLE 16 MEDTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 17 NOVO NORDISK: MAJOR PRODUCT OFFERINGS

TABLE 18 SANOFI: MAJOR PRODUCT OFFERINGS

TABLE 19 BD: MAJOR PRODUCT OFFERINGS

TABLE 20 BIOCON: MAJOR PRODUCT OFFERINGS

TABLE 21 EMPERRA GMBH E-HEALTH TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 22 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT: MAJOR PRODUCT OFFERINGS

TABLE 23 HK ZION INDUSTRY: MAJOR PRODUCT OFFERINGS

TABLE 24 JIANGSU DELFU MEDICAL DEVICE: MAJOR PRODUCT OFFERINGS

TABLE 25 OWEN MUMFORD: MAJOR PRODUCT OFFERINGS

TABLE 26 PENDIQ: MAJOR PRODUCT OFFERINGS

TABLE 27 SHANGHAI UMITAI MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 28 SUN MEDICAL PRODUCTS: MAJOR PRODUCT OFFERINGS

TABLE 29 SUZHOU PENG YE MEDICAL DEVICES: MAJOR PRODUCT OFFERINGS

TABLE 30 TRIONES TECHNOLOGY (GUANGZHOU): MAJOR PRODUCT OFFERINGS

TABLE 31 YPSOMED: MAJOR PRODUCT OFFERINGS

TABLE 32 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 33 GLOBAL INSULIN PENS MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 34 GLOBAL INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 35 GLOBAL INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 36 GLOBAL INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 37 GLOBAL INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 38 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 39 GLOBAL INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 40 NORTH AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 41 NORTH AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 42 NORTH AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 43 NORTH AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 44 NORTH AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 45 NORTH AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 46 APAC INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 47 APAC INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 48 APAC INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 49 APAC INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 50 APAC INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 51 APAC INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 52 EUROPE INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 53 EUROPE INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 54 EUROPE INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 55 EUROPE INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 56 EUROPE INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 57 EUROPE INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 58 LATIN AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 59 LATIN AMERICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 60 LATIN AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 61 LATIN AMERICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 62 LATIN AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 63 LATIN AMERICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

TABLE 64 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY PRODUCT 2021-2027 ($ MILLION)

TABLE 65 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY PRODUCT 2021-2027 (%)

TABLE 66 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY USAGE 2021-2027 ($ MILLION)

TABLE 67 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY USAGE 2021-2027 (%)

TABLE 68 MIDDLE EAST & AFRICA MARKET INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 ($ MILLION)

TABLE 69 MIDDLE EAST & AFRICA INSULIN PENS MARKET BY DISTRIBUTION CHANNEL 2021-2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Interested in data center portfolio for this report?
Click here

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date